Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Serco Group PLC Board/Management Information 2020

May 28, 2020

5273_mang_2020-05-28_2991ea75-37b1-4541-b0ce-a30dd3c6cc2b.html

Board/Management Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 2585O

Serco Group PLC

28 May 2020

28 May 2020

Serco Group plc

LEI: 549300PT2CIHYN5GWJ21

Serco Group plc ('Serco' or 'the Group'), the international service company, today announces that it has started a process to identify a successor for its current Chairman, Sir Roy Gardner.  

Sir Roy Gardner has been Chairman of Serco since 2015 and has been instrumental in leading the turnaround of the business during his tenure.  Sir Roy has decided that he will not seek another term and has asked the Board to start the process to find a successor.

The succession process is being managed by the Nomination Committee. The new Chairman is expected to be in place before the 2021 AGM.

For further information please contact Serco:

Paul Checketts, Head of Investor Relations T +44 (0) 7718 195074

Marcus De Ville, Head of Media Relations T +44 (0) 7738 898 550

About Serco

Serco is a leading provider of public services. Our customers are governments or others operating in the public sector.  We gain scale, expertise and diversification by operating internationally across five sectors and four geographies: Defence, Justice & Immigration, Transport, Health and Citizen Services, delivered in UK & Europe, North America, Asia Pacific and the Middle East.

More information can be found at www.serco.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

BOASEUFDAESSEFI